News
Announcement: Richard Sewalt new Chief Commercial Officer (CCO) at BioConnection
Oss, NL September 2, 2024 We are excited to announce that Richard Sewalt has joined BioConnection as our new Chief Commercial Officer (CCO). With his extensive background and proven expertise, Richard will be a key driver of our continued success and growth. Richard...
Announcement: Richard Sewalt new Chief Commercial Officer (CCO) at BioConnection
Oss, NL September 2, 2024 We are excited to announce that Richard Sewalt has joined BioConnection as our new Chief Commercial Officer (CCO). With his extensive background and proven expertise, Richard will be a key driver of our continued success and growth. Richard...
BioConnection appoints Dr. Gary M. Phillips as the new Chairman of the Supervisory Board
Oss, NL August 26, 2024 BioConnection is pleased to announce the appointment of Dr. Gary M. Phillips as the new Chairman of the Supervisory Board....
Strategic partnership AGC Biologics and BioConnection
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), and BioConnection, a specialized...
BioConnection congratulates BioLineRx with their FDA approval of Aphexda
BioConnection congratulates BioLineRx with their FDA approval of Aphexda. We are proud that we have been able to support BioLineRx since the start...
Dutch CDMO BioConnection announces substantial investment by Gimv, supported by existing shareholders
New capital secures growth acceleration in services for small to medium sized biopharmaceutical companies and further enhancement of quality control...
BioConnection to manufacture clinical trial material for Nykode Therapeutics’ vaccine
Oss, The Netherlands, 29 November 2021 BioConnection, an independent CDMO (Contract Development Manufacturing Organization) based in Oss, The...
GMP certification for new large scale filling line
Oss, The Netherlands, June 28, 2021. BioConnection received today from the Dutch Healthcare Inspectorate (IGJ) the GMP certification and...